Clinical outcomes of children and adolescents with sickle cell disease and COVID-19 infection: A year in review at a metropolitan tertiary pediatric hospital
BackgroundCOVID-19 was declared a global pandemic in March 2020. Early reports were primarily in adults, and sickle cell disease (SCD) was classified as a risk factor for severe COVID-19 disease. However, there are a limited number of primarily multi-center studies reporting on the clinical course o...
Main Authors: | Olufunke Y. Martin, Deepika S. Darbari, Stefanie Margulies, Robert S. Nickel, Alexis Leonard, Barbara Speller-Brown, Brenda Martin, John R. Barber, Jennifer Webb, Suvankar Majumdar, Matthew P. Sharron, Andrew D. Campbell |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-02-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2023.987194/full |
Similar Items
-
Complementary and Integrative Medicine Use in Pediatric Patients with Sickle Cell Disease
by: Lisa Thaniel, et al.
Published: (2022-05-01) -
5613043 THE EVOLUTION OF THE COVID-19 PANDEMIC IN PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE: FROM ALPHA TO OMICRON
by: O.Y. Martin, et al.
Published: (2023-04-01) -
Manifestations of HbSE sickle cell disease: a systematic review
by: Ibrahim Khamees, et al.
Published: (2021-06-01) -
Asymptomatic malaria parasitaemia in sickle-cell disease patients: how effective is chemoprophylaxis ?
by: Rachel Kotila, et al.
Published: (2007-03-01) -
Genotypic and Phenotypic Composition of Sickle Cell Disease in the Arab Population - A Systematic Review
by: Ata F, et al.
Published: (2023-02-01)